Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Lois E. Krahn"'
Autor:
Chad M. Ruoff, Yasemin S. Tashman, Kamal Preet K. Cheema, Bernie W. Miller, Ryan F. Houser, Matthew J. Lizak, Caitlin C. Haley, Ann M. Petersen, Umesh Goswami, Philip J. Lyng, Lois E. Krahn, Komandoor Srivathsan
Publikováno v:
Journal of Clinical Sleep Medicine. 19:941-946
Publikováno v:
Sleep Medicine. 102:142-146
Autor:
Alon Y. Avidan, Christopher G. Harrod, William A. DeBassio, Donna L. Arand, Chad M Ruoff, David G Davila, Lois E. Krahn
Publikováno v:
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, vol 17, iss 12
J Clin Sleep Med
J Clin Sleep Med
This article updates the American Academy of Sleep Medicine protocols for the administration of the Multiple Sleep Latency Test and the Maintenance of Wakefulness Test. The American Academy of Sleep Medicine commissioned a task force of clinical expe
Publikováno v:
Sleep Medicine. 81:210-217
To evaluate the efficacy of pitolisant, a histamine 3 (HData were pooled from two randomized, placebo-controlled, 7- or 8-week studies of pitolisant (titrated to a potential maximum dose of 35.6 mg/day) in adults with narcolepsy. Analyses included th
Autor:
W. Leroy Griffing, Clinton Jokerst, Lois E. Krahn, Hassan A. Raza, Phillip J Lyng, Matthew R. Neville, Lewis J. Wesselius, Rodrigo Cartin-Ceba, Sarah B. Umar, Brandon Nokes, Atul Malhotra, James M. Parish
Publikováno v:
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, vol 15, iss 11
J Clin Sleep Med
J Clin Sleep Med
STUDY OBJECTIVES: Scleroderma is associated with abnormal skin thickening, interstitial lung disease, pulmonary hypertension, and abnormalities of the upper airway. These changes can cause cardiopulmonary complications, potentially including sleep-di
Publikováno v:
Sleep. 43:A289-A290
Introduction Recent literature suggests that histamine may play an important role in narcolepsy. This post hoc analysis evaluates the efficacy of pitolisant, a histamine 3 (H3)-receptor antagonist/inverse agonist, in patients with high burden of the
Autor:
Michael J. Todd, John G. Park, Lois E. Krahn, Erik K. St. Louis, Kevin Hollingshead, Tsung Yen Yu, Coles M. Hoffmann, Timothy I. Morgenthaler, Matthew P. Buman, Dana R. Epstein, Megan E. Petrov, Kristina Hasanaj
Publikováno v:
Contemp Clin Trials
Background Positive airway pressure (PAP) therapy is the gold standard treatment for obstructive sleep apnea (OSA), a chronic disorder that affects 6–13% of the adult population. However, adherence to PAP therapy is challenging, and current approac
Publikováno v:
Sleep. 43:A304-A304
Introduction The ICSD-3 describes NREM-related parasomnias as abnormal sleep related complex movements where motor behavior occurs in the setting of absent or very minimal higher cognitive function. A population-based twin study reported that 3.9% of
Publikováno v:
Sleep Medicine. 64:S87
Publikováno v:
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 14(7)